Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Filters applied: . Clear all
Page 1
Carbamates as Potential Prodrugs and a New Warhead for HDAC Inhibition.
King K, Hauser AT, Melesina J, Sippl W, Jung M. King K, et al. Molecules. 2018 Feb 2;23(2):321. doi: 10.3390/molecules23020321. Molecules. 2018. PMID: 29393896 Free PMC article.
Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma).
Waldschmidt JM, Keller A, Ihorst G, Grishina O, Müller S, Wider D, Frey AV, King K, Simon R, May A, Tassone P, Duyster J, Jung M, Raje N, Wäsch R, Engelhardt M. Waldschmidt JM, et al. Among authors: king k. Haematologica. 2018 Oct;103(10):e473-e479. doi: 10.3324/haematol.2018.189969. Epub 2018 Apr 19. Haematologica. 2018. PMID: 29674494 Free PMC article. Clinical Trial. No abstract available.
Feedback